Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial

Fig. 2

Oxidative and inflammatory parameters. Blood was collected on enrollment and on the morning of the subsequent 2 days for the measurement of thiobarbituric acid reactive species (TBARS) (a), interleukin (IL)-6 (b), IL-8 (c), IL-10 (d), and protein carbonyls (e). *Different from time 0, same group. #Difference between groups at the same time point NAC + DFX N-acetylcysteine plus deferoxamine, MDA malondialdehyde

Back to article page

Critical Care

ISSN: 1364-8535